Zimmer Biomet
Zimmer Biomet Holdings, Inc. a global medical technology leader, has announced that it has signed a definitive agreement to acquire OrthoGrid Systems, Inc., (OrthoGrid) a privately-held medical technology company focused on artificial intelligence (AI)-driven surgical guidance systems for total hip replacement.
The acquisition includes OrthoGrid's AI-powered, fluoroscopy-based surgical assistance platform Hip AI, as well as two additional FDA-cleared orthopedic applications and over 40 patents.
Surgical guidance systems often rely on CT-based imaging which can result in a backlog of CT exams and, in turn, impact operating room (OR) workflow and efficiency. Fluoroscopy-based surgical guidance is a technique that uses real-time X-ray imaging to help guide procedures and improve surgical accuracy and safety.
Unlike CT scans, fluoroscopy-based systems do not require preoperative preparation, which OrthoGrid says allows for real-time navigation with up-to-date images, and provide convenient bedside access to motion imaging.
"OrthoGrid's AI systems address the rapidly growing market demand for fluoroscopy-based surgical guidance solutions while strengthening our portfolio of hip offerings that drive intraoperative efficiencies and improve the quality of life for patients," said Jim Lancaster, President, Recon and Global Headquarters Executive Director at Zimmer Biomet.
OrthoGrid's Hip AI system provides real-time image analysis, automated measurements of leg length and offset, and guidance on optimal cup placement while maintaining a small OR footprint. In addition, surgeons can tailor Hip AI to align with their specific technique and workflow.
"We pride ourselves on being customer-centric and Hip AI exemplifies our commitment to offer solutions that meet the specific needs of each surgeon," added Lancaster.
"The agreement with Zimmer Biomet, a global leader in orthopedics, will significantly accelerate our shared goal of addressing challenging orthopedic problems with innovative technology solutions," said Edouard Saget, Co-Founder and Co-Chief Executive Officer of OrthoGrid.
"While early, the launch of our AI-driven intraoperative surgical guidance platform has received positive feedback from hip surgeons across the U.S. and we are excited to expand our reach through this acquisition," said Richard Boddington, Co-Founder and Co-Chief Executive Officer of OrthoGrid.
The transaction is subject to customary closing conditions and is expected to be completed by the end of the fourth quarter of 2024.
